The dog erythrocyte antigen 1 blood group in nondomesticated canids and compatibility testing between domestic dog and nondomesticated canid blood

Evaluation of the prevalence of the dog erythrocyte antigen 1 blood type in dogs of Sydney

OBJECTIVE

This study aimed to evaluate the prevalence of dog erythrocyte antigen 1 (DEA 1) blood type in Sydney and to identify any associations between its prevalence and breed, sex and geographic location of these dogs.

METHODS

This was a retrospective study of 225 dogs that underwent DEA 1 blood typing while donating or receiving blood products at a single institution between 2020 and 2024. Dogs were DEA 1 positive or negative and blood donors or recipients. Logistic regression was used to evaluate differences in the prevalence of DEA 1 positive results between sex, breed and geographic location. Significance was set at P < 0.05. Reasons for blood transfusion, blood product administered and age were documented.

RESULTS

Of the dogs that were blood typed (n = 225), 48% (108/225) were DEA 1 positive and 52% (117/225) DEA 1 negative, 105 (46.7%) were donors and 120 (53.3%) recipients. The highest prevalence of DEA 1 type positivity was observed in the Golden Retriever (8/9, 88.9%). Recipients presented primarily for haemorrhage (57/120, 47.5%), most frequently receiving whole blood (89/120, 74.2%) with minimal adverse reactions (3/120, 2.5%). No significant differences were identified in prevalence of DEA 1 positive dogs between breed groups, six most common breeds, sex, geographical location or DEA 1 negative blood types.

CONCLUSIONS

The prevalence of the DEA 1 blood type in this cohort of dogs in Sydney is comparable to other countries.

Xenotransfusion of Blood from Dog to Cat: Should Canine Blood Be Our First Choice for Feline Transfusion in Emergency Situations?

Despite the ability to determine feline blood types, the transfusion of canine blood to cats is still practiced in some countries. Xenotransfusion is effective—even if its effects only last for a few days—and is not associated with serious adverse effects. It avoids the need for blood typing, and most importantly, it avoids the transmission of intraspecific infectious agents, notably the feline leukemia virus (FeLV). Transfusion with canine blood is easier, quicker and less costly than transfusion with feline blood; it is less disagreeable for the donor. In the light of these arguments, when feline blood collected according to current guidelines is not available, in particular when the donor is not confirmed to be negative for the FeLV provirus, the authors consider it to be judicious to use canine blood for feline transfusion in emergency situations; this practice is preferable to inaction and to the inoculation of an infectious agent. Allotransfusion remains preferable in non-emergency situations as a treatment of chronic compensated anaemiae or if an appropriate donor (negative for FeLV provirus) is available. However, 2–4 days after a xenotransfusion, if a clinical alteration and a significant decrease in haematocrit are observed, a transfusion with cat’s blood confirmed to be negative for FeLV provirus should be performed. Xenotransfusion should never be used twice.

The dog erythrocyte antigen 1 blood group in nondomesticated canids and compatibility testing between domestic dog and nondomesticated canid blood

Background

The dog erythrocyte antigen (DEA) 1 blood group is considered as the most immunogenic and clinically important in dogs. Little is known in nondomesticated canids.

Objectives

To type DEA 1 in nondomesticated captive canids and to evaluate potential interspecific blood transfusions between domestic and nondomestic canids.

Animals

One hundred forty captive nondomesticated canids belonging to 13 species from 19 French zoos, and 63 domestic dogs.

Methods

Prospective study. Blood samples were typed for DEA 1 using immunochromatographic and flow cytometric techniques. A neutral gel column test was used for crossmatching.

Results

Of 140 nondomesticated canids, 72.9% were DEA 1+ and 27.1% were DEA 1− using immunochromatographic technique and 74.3% were DEA 1+ and 25.7% were DEA 1− by flow cytometric technique.

Crossmatch (XM) between 140 nondomesticated canid red blood cells (RBCs) and plasma from a previously DEA 1+ sensitized DEA 1− dog revealed 112 incompatibilities (80%). Crossmatches between 130 nondomesticated canid serum and 1 or up to 8 donor dogs' RBCs revealed 99 of 130 (76%) compatibilities. Crossmatches between 115 nondomesticated canid RBCs and donor dogs' serum revealed 59 of 115 (51%) compatibilities.

Conclusions and Clinical Importance

Dog erythrocyte antigen 1 blood type is present in nondomesticated canids with variable prevalence depending on species. The majority of tested nondomesticated canids appear to have no naturally occurring alloantibodies against domestic dogs' RBCs. Therefore xenotransfusion of blood from domestic dogs can be considered when species specific blood is not available. Cross matching is essential before xenotransfusion.